Human diabetic mesenchymal stem cells from peripheral arterial disease patients promote angiogenesis through unique secretome signatures

Diabetic patients are at increased risk of complications from severe peripheral arterial disease. Mesenchymal stem cells (MSC) may be useful in limiting these complications. Our objective is to test the angiogenic potential of diabetic versus healthy MSCs.

Source: Surgery - February 3, 2018 Category: Surgery Authors: Andrew D. Morris, Sidd Dalal, Haiyan Li, Luke P. Brewster Source Type: research